Nektar Therapeutics (NKTR) Revenue History
Nektar Therapeutics (NKTR) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $165.44M |
| 2017-12-31 | $307.71M |
| 2018-12-31 | $1.19B |
| 2019-12-31 | $114.62M |
| 2020-12-31 | $152.91M |
| 2021-12-31 | $93.88M |
| 2022-12-31 | $92.06M |
| 2023-12-31 | $90.12M |
| 2024-12-31 | $98.43M |
| 2025-12-31 | $55.23M |
How NKTR compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| KURA | Kura Oncology Inc. | $67.48M |
| ENTA | Enanta Pharmaceuticals Inc. | $65.32M |
| OCUL | Ocular Therapeutix Inc. | $51.95M |
| GOSS | Gossamer Bio Inc. | $48.47M |
| AQST | Aquestive Therapeutics Inc. | $44.55M |
These are five companies in the same sector as NKTR with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Nektar Therapeutics Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("NKTR", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NKTR | $74.02 | -0.68% | 0.61M |
| 3 | ||||
| 4 | ||||
| 5 |